Pathstone Holdings
CNMD icon

Pathstone Holdings’s CONMED CNMD Stock Holding History

Pathstone Holdings’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,793
Closed -$201K – 2322
2024
Q3 		$201K Sell
2,793
-447
-14% -$31.5K ﹤0.01% 2171
2024
Q2 		$225K Sell
3,240
-4,775
-60% -$348K ﹤0.01% 2095
2024
Q1 		$642K Buy
8,015
+3,685
+85% +$328K ﹤0.01% 1555
2023
Q4 		$474K Buy
+4,330
New +$448K ﹤0.01% 1534

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pathstone Holdings's CNMD Position: Q4 2024 in Review

Pathstone Holdings sold out of CONMED (CNMD) in Q4 2024, closing a stake of 2,793 shares — an estimated $201K sold.

Pathstone Holdings first reported a position in CNMD in Q4 2023 and held it in 4 quarters. The position peaked at $642K in Q1 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Pathstone Holdings reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Pathstone Holdings sold 2,793 CONMED shares in Q4 2024, an estimated $201K.
  • Pathstone Holdings first reported a position in CONMED in Q4 2023 and held it in 4 quarters.
  • Pathstone Holdings's CONMED position peaked at $642K in Q1 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Pathstone Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.